CN102743594A - Chinese medicine composition for treating chronic renal failure - Google Patents
Chinese medicine composition for treating chronic renal failure Download PDFInfo
- Publication number
- CN102743594A CN102743594A CN2012102515450A CN201210251545A CN102743594A CN 102743594 A CN102743594 A CN 102743594A CN 2012102515450 A CN2012102515450 A CN 2012102515450A CN 201210251545 A CN201210251545 A CN 201210251545A CN 102743594 A CN102743594 A CN 102743594A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- medicine composition
- renal failure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicine composition for treating chronic renal failure. Traditional Chinese medicine holds that the chronic renal failure belongs to the category of 'consumptive disease' and 'uroschesis', and the pathogenesis of the chronic renal failure is deficiency of spleen and kidney and turbidity blockade. Therefore, the Chinese medicine composition comprises Chinese medicines including rust-coloured crotalaria herb with root, satyrium root, dried rehmannia root, radix astragali, cinnamon, concha ostreae, radix scutellariae, philippine flemingia root, sticktight and summer purslane, and enema is prepared by a preparation room of the institution. After clinical test, the total effective rate is 97.4%, Scr (serum creatinine) and BUN (blood urea nitrogen) reduction of a control group is obviously superior to that of an existing control group, and the Chinese medicine composition is low in treatment cost, simple and convenient in method and worthy of clinical popularization and application.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine composition of treating chronic renal failure.
Background technology
Chronic renal failure is clinical common critical illness, and it is the severe renal material injury that various Secondary cases and constitutional nephropathy develop into the later stage, belongs to the late period of kidney disease.Adopt means such as renal transplantation, hemodialysis to treat for uremic patient more, but high medical expense, and donor kidney source difficulty, for the actual clinical treatment has brought very big trouble.Therefore, take active and effective treatment means, can delay the progress of disease in early stage, the mid-term of chronic renal failure.At present uremic Therapeutic Method is adopted the intestinal dialysis Drug therapy more,, realize the discharge of uremic toxins such as carbamide, guanidine class, creatinine etc. through the excretory function of intestinal.Clinical practice proves, utilizes the herbal drug enema in treatment chronic renal failure to have good effect, cost is low, side effect is little advantage.
According to chronic renal failure early, the pathogenesis of mid-term asthenia of both the spleen and kidney, turbid tired retardance drafted the spleen reinforcing kidney and promoting blood circulation and let out turbid side.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition of treating chronic renal failure.The traditional Chinese medical science thinks that chronic renal failure belongs to " asthenia " " difficulty in urination " category, and its pathogenesis is asthenia of both the spleen and kidney, turbid tired retardance.Chinese traditional treatment is with invigorating spleen and kidney, and damp eliminating the turbid descending, promoting blood circulation and detoxication are the rule of treatment.
The objective of the invention is to realize that through following technical scheme this a kind of Chinese medicine composition of treating chronic renal failure is processed by following parts by weight of Chinese traditional medicine: Herba Crotalariae Ferrugineae 15-20 part, Radix Satyrii nepalensis 15-20 part, Radix Rehmanniae 10-15 part, Radix Astragali 10-15 part, Cortex Cinnamomi 5-7 part, Concha Ostreae 15-18 part, Radix Scutellariae 12-15 part, Radix Flemingiae Philippinensis 12-15 part, Herba Bidentis Bipinnatae 18-20 part, Herba portulacae 11-13 part.
Preferably, 18 parts of Herba Crotalariae Ferrugineaes, 18 parts of Radix Satyrii nepalensiss, 14 parts of Radix Rehmanniae, 14 parts of the Radixs Astragali, 6 parts of Cortex Cinnamomis, 16 parts of Concha Ostreaes, 13 parts of Radix Scutellariaes, 13 parts of Radix Flemingiae Philippinensiss, 19 parts of Herba Bidentis Bipinnatae, 12 parts of Herba portulacaes.
In the side: Herba Crotalariae Ferrugineae: go into lung; The gas of astringing the lung, spleen reinforcing kidney, diuresis, detumescence poison.
Radix Satyrii nepalensis: go into kidney channel; The kidney invigorating is nourished heart, and controls sexual impotence, chronic nephritis.
Radix Rehmanniae: GUIXIN, liver, kidney channel; Clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting.
The Radix Astragali: return spleen, lung meridian; Tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, promoting pus discharge and tissue regeneration strengthening, inducing diuresis to remove edema.
Cortex Cinnamomi: return kidney, spleen, the heart, Liver Channel; It is supporing yang to mend fire, dispersing cold for relieving pain, promoting the flow of QI-blood by warming the meridian.
Concha Ostreae: go into liver, kidney channel; Suppressing the hyperactive liver and subsiding YANG, restrain astringent or styptic treatment for spontaneous sweating, hard masses softening and resolving.
Radix Scutellariae: return lung, gallbladder, stomach, large intestine channel; Heat clearing and damp drying, eliminating fire and detoxication.
Radix Flemingiae Philippinensis: go into lung, kidney, urinary bladder channel; Expelling wind and removing dampness, bone and muscle strengthening, promoting blood circulation and detoxication.
Herba Bidentis Bipinnatae: go into Liver Channel, lung meridian, large intestine channel; Heat-clearing and toxic substances removing, expelling wind and removing dampness, promoting blood circulation and detumescence.
Herba portulacae: return large intestine, Liver Channel; Heat-clearing and toxic substances removing, eliminating pathogenic heat from blood to cure dysentery.
Clinical data
All cases of physical data are outpatient service and the inpatient who goes to a doctor at my institute's Urology Department in November, 2008~2009 year November, select to meet diagnostic criteria and 156 examples of including standard in, are divided into respectively 78 examples of treatment group and matched group at random.Matched group man 50 examples, women 28 examples; 23~66 years old age, average 44.5 years old; Male 42 examples are organized in treatment, women 36 examples; 24~67 years old age, average 45.5 years old; Two groups of not statistically significants (P<0.05) aspect sex, age, sick kind composition have comparability.
Therapeutic Method treatment group adopts Chinese medicine composition coloclysis of the present invention, gets Herba Crotalariae Ferrugineae 18 grams, Radix Satyrii nepalensis 18 grams, Radix Rehmanniae 14 grams, the Radix Astragali 14 grams, Cortex Cinnamomi 6 grams, Concha Ostreae 16 grams, Radix Scutellariae 13 grams, Radix Flemingiae Philippinensis 13 grams, Herba Bidentis Bipinnatae 19 grams, Herba portulacae 12 grams, adds 500 milliliters in water; Water boiling concentration to 200 milliliter treats that fluid temperature drops to human body temperature to be adapted to coloclysis when suitable that the patient gets lateral position; Raise buttocks, aseptic enema tube is slowly inserted anus, insert 3-5cm; When coloclysis finishes the flat buttocks that crouches of patient is raised 10~15cm; Medicament was kept 30 minutes at enteral, and every day 1 time, 7 days is 1 course of treatment; The oral love Seat of matched group; All treat for two groups and add up curative effect three courses of treatment.
Criterion of therapeutical effect is evaluated referring to national renal failure conservative treatment special topic academic conference in 1989 and Clinical Researches of New Drugs guideline specified standard.Sx or disappearance, endogenous creatinine clearance rate (Ccr) increases >=30%, and serum creatinine (Scr) decline >=30% is produce effects; Sx or disappearance, endogenous creatinine clearance rate increases (Ccr) >=20%, and serum creatinine (Scr) decline >=20% is effective; Treatment back subjective symptoms and sign do not alleviate or increase the weight of to invalid.
Renal function changed two groups of treatment back Scr before and after 1. therapeutic outcome treated, BUN all obviously descend, and relatively reaching before and after the treatment more all has significant difference (P<0.05) between group, but with matched group difference relatively (P<0.01).See table 2
Annotate: compare * * P<0.01) with matched group
2. two groups of treatment two all backs curative effects are relatively seen table 2.
Table 2 liang group curative effect is [example (%)] relatively
The treatment group always has rate to reach 97.4%, and the matched group total effective rate reaches 80.8%, and the treatment group obviously is superior to matched group, and two groups of cure rates, total effective rates have significant difference (P<0.05).
The specific embodiment
Embodiment one: take by weighing Herba Crotalariae Ferrugineae 18g, Radix Satyrii nepalensis 18g, Radix Rehmanniae 14g, Radix Astragali 14g, Cortex Cinnamomi 6g, Concha Ostreae 16g, Radix Scutellariae 13g, Radix Flemingiae Philippinensis 13g, Herba Bidentis Bipinnatae 19g, Herba portulacae 12g.Add 500 milliliters in water, water boiling concentration to 200 milliliter is treated before the coloclysis that fluid temperature drops to human body temperature to be adapted to coloclysis when suitable; The patient gets lateral position, raises buttocks, and aseptic enema tube is slowly inserted anus; Insert 3-5cm, when coloclysis finishes the flat buttocks that crouches of patient is raised 10~15cm, make medicament keep 30~60min at enteral; Every day 1 time, 7 days is 1 course of treatment.
Embodiment two: take by weighing Herba Crotalariae Ferrugineae 15g, Radix Satyrii nepalensis 15g, Radix Rehmanniae 10g, Radix Astragali 10g, Cortex Cinnamomi 5g, Concha Ostreae 15g, Radix Scutellariae 12g, Radix Flemingiae Philippinensis 12g, Herba Bidentis Bipinnatae 18g, Herba portulacae 11g.Add 600 milliliters in water, water boiling concentration to 230 milliliter is treated that fluid temperature drops to human body temperature to be adapted to coloclysis when suitable; The patient gets lateral position, raises buttocks, and aseptic enema tube is slowly inserted anus; Insert 3-5cm, when coloclysis finishes the flat buttocks that crouches of patient is raised 10~15cm, make medicament keep 30~60min at enteral; Every day 1 time, 7 days is 1 course of treatment.
Embodiment three: take by weighing Herba Crotalariae Ferrugineae 20g, Radix Satyrii nepalensis 20g, Radix Rehmanniae 15g, Radix Astragali 15g, Cortex Cinnamomi 7g, Concha Ostreae 18g, Radix Scutellariae 15g, Radix Flemingiae Philippinensis 15g, Herba Bidentis Bipinnatae 19g, Herba portulacae 13g.Add 550 milliliters in water, water boiling concentration to 210 milliliter is treated that fluid temperature drops to human body temperature to be adapted to coloclysis when suitable; The patient gets lateral position, raises buttocks, and aseptic enema tube is slowly inserted anus; Insert 3-5cm, when coloclysis finishes the flat buttocks that crouches of patient is raised 10~15cm, make medicament keep 30~60min at enteral; Every day 1 time, 7 days is 1 course of treatment.
Claims (2)
1. Chinese medicine composition of treating chronic renal failure is characterized in that this Chinese medicine composition processed by following parts by weight of Chinese traditional medicine: Herba Crotalariae Ferrugineae 15-20 part, Radix Satyrii nepalensis 15-20 part, Radix Rehmanniae 10-15 part, Radix Astragali 10-15 part, Cortex Cinnamomi 5-7 part, Concha Ostreae 15-18 part, Radix Scutellariae 12-15 part, Radix Flemingiae Philippinensis 12-15 part, Herba Bidentis Bipinnatae 18-20 part, Herba portulacae 11-13 part.
2. a kind of Chinese medicine composition of treating chronic renal failure according to claim 1 is characterized in that this Chinese medicine composition processed by following parts by weight of Chinese traditional medicine: 18 parts of Herba Crotalariae Ferrugineaes, 18 parts of Radix Satyrii nepalensiss, 14 parts of Radix Rehmanniae, 14 parts of the Radixs Astragali, 6 parts of Cortex Cinnamomis, 16 parts of Concha Ostreaes, 13 parts of Radix Scutellariaes, 13 parts of Radix Flemingiae Philippinensiss, 19 parts of Herba Bidentis Bipinnatae, 12 parts of Herba portulacaes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210251545.0A CN102743594B (en) | 2012-07-10 | 2012-07-10 | Chinese medicine composition for treating chronic renal failure |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210251545.0A CN102743594B (en) | 2012-07-10 | 2012-07-10 | Chinese medicine composition for treating chronic renal failure |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102743594A true CN102743594A (en) | 2012-10-24 |
CN102743594B CN102743594B (en) | 2014-01-01 |
Family
ID=47024323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210251545.0A Expired - Fee Related CN102743594B (en) | 2012-07-10 | 2012-07-10 | Chinese medicine composition for treating chronic renal failure |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102743594B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690850A (en) * | 2013-12-22 | 2014-04-02 | 杨洪军 | Traditional Chinese medicinal enema for treating chronic renal failure |
CN105641434A (en) * | 2016-01-02 | 2016-06-08 | 马成燕 | Traditional Chinese medicine for treating chronic renal failure and preparation method thereof |
CN107468849A (en) * | 2017-09-11 | 2017-12-15 | 贵阳中医学院第二附属医院 | A kind of medicine for treating chronic renal failure and preparation method thereof |
CN114224941A (en) * | 2022-02-08 | 2022-03-25 | 上海市奉贤区中医医院 | Traditional Chinese medicine composition for treating chronic renal failure and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682780A (en) * | 2004-04-14 | 2005-10-19 | 张鸣鸣 | Medicine for treating uaemia and insufficiency of kidney-yang and kidney exhaustion and its preparing method |
CN101024053A (en) * | 2007-02-08 | 2007-08-29 | 毕哲全 | Chinese medicine for treating chronic kidney disease |
CN101766777A (en) * | 2009-12-29 | 2010-07-07 | 吉林省现代中药研究开发中心 | Chinese medicine composite for treating chronic renal failure |
-
2012
- 2012-07-10 CN CN201210251545.0A patent/CN102743594B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682780A (en) * | 2004-04-14 | 2005-10-19 | 张鸣鸣 | Medicine for treating uaemia and insufficiency of kidney-yang and kidney exhaustion and its preparing method |
CN101024053A (en) * | 2007-02-08 | 2007-08-29 | 毕哲全 | Chinese medicine for treating chronic kidney disease |
CN101766777A (en) * | 2009-12-29 | 2010-07-07 | 吉林省现代中药研究开发中心 | Chinese medicine composite for treating chronic renal failure |
Non-Patent Citations (3)
Title |
---|
彭贵阳: "肾虚耳鸣的中医药治疗及药理探讨", 《中国中西医结合耳鼻咽喉科杂志》, vol. 2, no. 3, 31 December 1994 (1994-12-31) * |
金华: "中药复方合剂灌肠治疗慢性肾衰竭122例临床观察", 《时珍国医国药》, vol. 17, no. 7, 31 December 2006 (2006-12-31) * |
陈奇: "《中药药效研究思路与方法》", 28 February 2005, article "慢性肾衰竭的中药药效研究思路与方法" * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103690850A (en) * | 2013-12-22 | 2014-04-02 | 杨洪军 | Traditional Chinese medicinal enema for treating chronic renal failure |
CN103690850B (en) * | 2013-12-22 | 2016-05-11 | 黄军业 | A kind of Chinese medicinal enema for the treatment of chronic kidney hypofunction |
CN105641434A (en) * | 2016-01-02 | 2016-06-08 | 马成燕 | Traditional Chinese medicine for treating chronic renal failure and preparation method thereof |
CN107468849A (en) * | 2017-09-11 | 2017-12-15 | 贵阳中医学院第二附属医院 | A kind of medicine for treating chronic renal failure and preparation method thereof |
CN107468849B (en) * | 2017-09-11 | 2020-12-29 | 贵阳中医学院第二附属医院 | Medicine for treating chronic renal failure and preparation method thereof |
CN114224941A (en) * | 2022-02-08 | 2022-03-25 | 上海市奉贤区中医医院 | Traditional Chinese medicine composition for treating chronic renal failure and application thereof |
CN114224941B (en) * | 2022-02-08 | 2023-04-25 | 上海市奉贤区中医医院 | Traditional Chinese medicine composition for treating chronic renal failure and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN102743594B (en) | 2014-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100569276C (en) | A kind of Chinese medicine for the treatment of chronic nephropathy | |
CN101766773B (en) | Chinese medicine prescription for treating talagia | |
CN101167817B (en) | Traditional Chinese medicine for treating migraine | |
CN102743594B (en) | Chinese medicine composition for treating chronic renal failure | |
CN106266463B (en) | Traditional Chinese medicine composition for treating hyperuricemia and application thereof | |
CN102600392B (en) | Traditional Chinese medicine enema for treating chronic renal failure | |
CN102552862A (en) | Preparation method of traditional Chinese medicine for treatment of yang deficiency, qi stagnation and blood stasis type chronic pelvic inflammatory disease | |
CN102764360B (en) | Traditional Chinese medicine composition for treating acute cystitis | |
CN103784932A (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
CN102145099A (en) | Traditional Chinese medicine for treating infertility caused by liver stagnation | |
CN101455755B (en) | Yang-strengthening preparation for treating yang-insufficiency type impotence and preparation method thereof | |
CN104056200B (en) | Oral traditional Chinese medicine combination for treating lumbar spinal stenosis | |
CN103877216B (en) | One treats myocarditic Chinese drugs agentia and preparation method | |
CN102961612B (en) | Traditional Chinese medicine capsule for treating ankylosing spondylitis | |
CN101954043A (en) | Medicament for treating hyperosteogeny and preparation method thereof | |
CN101507756A (en) | Medicine for treating hemiplegia | |
CN104524090A (en) | Traditional Chinese medicine preparation for treating sequelae of head injury | |
CN106236857A (en) | A kind of Chinese medicine composition treating chronic renal failure and preparation method thereof, preparation and application | |
CN104491799B (en) | A kind of traditional Chinese powder medicine for application treatment rheumatoid arthritis | |
CN103599294B (en) | Traditional Chinese medicine liquid extract for treating ankylosing spondylitis | |
CN104491703A (en) | Oral traditional Chinese medicine composition for treating traumatic synovitis of knee joint | |
CN101439110B (en) | Chinese medicine for curing rheumatism | |
CN104435996A (en) | Chinese medicine preparation for treating pancytopenia | |
CN104491327A (en) | Spraying agent for treating bedsore | |
CN103349720A (en) | Traditional Chinese medicine composition for treating acute cystitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140101 Termination date: 20140710 |
|
EXPY | Termination of patent right or utility model |